Literature DB >> 2556726

Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.

K W Locke1, B Gorney, M Cornfeldt, S Fielding.   

Abstract

The opioid receptor selectivity of the EKC discriminative stimulus was characterized in Fischer rats trained to discriminate 0.3 mg/kg EKC (SC) from saline in a two-choice discrete-trial avoidance paradigm. The putative kappa-opioid receptor agonists EKC and U50,488H completely generalized with the EKC cue at doses of 0.3 and 10 mg/kg, respectively. The putative mu-opioid receptor agonists morphine (M) and fentanyl also dose-dependently generalized with the EKC stimulus. The generalization of M with EKC was not symmetrical, EKC and U50,488H produced little or no M-appropriate responding in rats trained to discriminate 3.0 mg/kg M (SC) from saline. This generalization pattern may reflect a lack of opioid receptor selectivity of the EKC stimulus. However, distinct mu-opioid and kappa-opioid components of the EKC cue could be identified using graded doses of naloxone in EKC-trained rats. The discriminative effects of morphine and fentanyl were blocked completely by doses of 0.1-1.0 mg/kg naloxone, whereas doses of naloxone 3-10 times greater were necessary to block the discriminative effects of EKC and U50,488H. These results suggest that EKC produces a complex discriminative stimulus with mu-opioid and kappa-opioid components that can be separated using antagonists such as naloxone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556726     DOI: 10.1007/BF00589897

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

Review 3.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.

Authors:  S Herling; J H Woods
Journal:  Life Sci       Date:  1981-04-06       Impact factor: 5.037

4.  Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.

Authors:  G T Shearman; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

5.  Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.

Authors:  M Picker; L A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

6.  Further evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

7.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

8.  Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

9.  Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.

Authors:  G T Shearman; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

Authors:  H W Kosterlitz; S J Paterson; L E Robson
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more
  4 in total

1.  Drug discrimination in pigeons trained to discriminate among morphine, U50488, a combination of these drugs, and saline.

Authors:  William D Wessinger; Mi Li; Donald E McMillan
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.

Authors:  S G Holtzman; L Cook; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.

Authors:  S S Negus; D Morgan; C D Cook; M J Picker
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

4.  Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.

Authors:  M Ohno; T Yamamoto; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.